Skip to main content
. 2017 Oct 24;12(10):e0186508. doi: 10.1371/journal.pone.0186508

Table 1. Characterization of the PD cohort according to IGF-1 quartiles.

Total cohort (405) The lowest quartile (110) The second quartile (86) The third quartile (100) The highest quartile (109) p
IGF-1, ng/ml 33.800–412.200 ≤ 97.9 97.9001–124 124.0001–162.200 ≥ 162.2001 NA
Demographic and motor variables
Age, years 61.20 (9.76) (33, 84) 63.33 (9.04) (33, 85) 60.62 (11.63) (33, 82) 62.14 (11.91) (33, 83) 61.07 (10.44) (33, 82) 0.278
Gender (M/F) 264/141 58/52 (52.70/47.30) 62/24 (72.10/27.90) 65/35 (65/35) 79/30 (72.50/27.50) <0.05*
BMI 27.20 (5.10) (16.80, 45) 26.92 (6.62) (18.18, 45) 28.01 (4.64) (19.65, 41.57) 27.21 (4.61) (17.72,41.05) 26.95 (3.91) (16.80, 36.85) 0.437
Education, years 15.56 (2.98) (5, 26) 15.25 (3.35) (5, 22) 15.84 (3.37) (8, 26) 15.39 (2.67) (8, 24) 15.76 (2.53) (11, 23) 0.443
Disease duration, months 6.33 (6) (0, 35) 5.8 (4.31) (0, 28) 5.92 (5.71) (4, 35) 6.21 (5.81) (6, 30) 6.51 (5.72) (8, 28) 0.499
MDS-UPDRS-III 20.25 (8.93) (4, 51) 21.03 (9.38) (6, 51) 20.87 (7.42) (6, 39) 18.44 (8.52) (6, 45) 20.55 (9.81) (4, 49) 0.140
Cognitive variables
MoCA, total score 27.10 (2.34) (17, 30) 27 (2.37) (19, 30) 27.02 (2.32) (17, 30) 27.62 (2.08) (21, 30) 26.86 (2.51) (17, 30) 0.078
JOLO 12.69 (2.23) (5, 15) 12.81 (2.41) (5,15) 12.76 (2.28) (5,15) 12.96 (2.08) (7,15) 12.3 (2.13) (6, 15) 0.164
HVLT IR 24.45 (4.99) (9, 36) 24.11 (4.88) (11, 32) 24.52 (5.15) (14, 34) 25.49 (4.89) (9, 35) 24.86 (5.02) (13, 36) 0.097§
HVLT DRLY 8.36 (2.52) (0, 12) 7.95 (2.72) (0, 12) 8.56 (2.14) (3, 12) 8.79 (2.57) (0, 12) 8.22 (2.51) (0, 12) 0.084^
HVLT retention 0.85 (0.20) (0, 1.29) 0.81 (0.22) (0, 1.22) 0.89 (0.16) (0.44, 1.29) 0.86 (0.19) (0, 1.22) 0.85 (0.21) (0, 1.29) 0.074°
HVLT DR 9.65 (2.54) (-2, 12) 9.51 (2.52) (-1, 12) 9.73 (2.52) (-1, 12) 9.89 (2.54) (0, 12) 9.55 (2.61) (-2, 12) 0.683
LNS 10.56 (2.66) (2–20) 10.15 (2.92) (4, 20) 10.41 (2.56) (2, 16) 10.68 (2.71) (3, 20) 10.98 (2.38) (5, 17) 0.120
Semantic fluency 48.52 (11.72) (20, 103) 46.31 (10.73) (20, 75) 49.15 (12.19) (26, 83) 50.13 (11.37) (25, 91) 48.77 (12.36) (24, 103) 0.100$
SDMT 41.17 (9.78) (7, 82) 38.89 (9.88) (7, 61) 41.76 (10.74) (20, 82) 41.77 (8.9) (16, 70) 42.54 (9.35) (17, 66) 0.036&

Data are in mean (SD) (range), unless otherwise specified. Significance level≤0.1 are shown in italics.

* p = 0.005 for the lowest versus the second quartile; p = 0.002 for the lowest versus the fourth quartile.

§ -0.403, p = 0.937 for the lowest versus the second quartile; -1.370, p = 0.286 for the lowest versus the third quartile; -0.256, p = 0.989 for the lowest versus the highest quartile.

^ -0.615, p = 0.543 for the lowest versus the second quartile; -0.835, p = 0.101 for the lowest versus the third quartile; -0.266, p = 0.787 for the lowest versus the highest quartile.

° -0.075, p = 0.060 for the lowest versus the second quartile; -0.045, p = 0.608 for the lowest versus the third quartile; -0.040, p = 0.811 for the lowest versus the highest quartile

$ -2.848, p = 0.547 for the lowest versus the second quartile; -3.827, p = 0.109 for the lowest versus the third quartile; -2.468, p = 0.714 for the lowest versus the highest quartile

& -2.866, p = 0.247 for the lowest versus the second quartile; -2.88, p = 0.196 for the lowest versus the third quartile; -3.560, p = 0.042 for the lowest versus the highest quartile

BMI: Body Mass Index; HVLT DLRY: Hopkins Verbal Learning Test Delayed Recall; HVLT DR: Hopkins Verbal Learning Test Discrimination Recognition; HVLT IR: Hopkins Verbal Learning Test Immediate Recall; JOLO: Benton Judgment of Line Orientation (15-item version); LNS: Letter Number Sequencing; MDS-UPDRS-III: Movement Disorders Society version of the Unified Parkinson’s disease rating scale part III; MoCA: Montreal Cognitive Assessment; SDMT: Symbol Digit Modalities Test.